Bekker L-G, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, et al. HIV infection. Nat Rev Dis Primers. 2023;9(1):42.

Article  PubMed  Google Scholar 

Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells. Nat Med. 2003;9(6):727–8.

Article  CAS  PubMed  Google Scholar 

Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295–300.

Article  CAS  PubMed  Google Scholar 

Fauci AS, Lane HC. Four decades of HIV/AIDS - much accomplished, much to Do. N Engl J Med. 2020;383(1):1–4.

Article  PubMed  Google Scholar 

Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38.

Article  CAS  PubMed  Google Scholar 

Singal R, Ginder GD. DNA methylation. Blood. 1999;93(12):4059–70.

Article  CAS  PubMed  Google Scholar 

Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14(3):204–20.

Article  CAS  PubMed  Google Scholar 

Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6(8):597–610.

Article  CAS  PubMed  Google Scholar 

Conerly M, Grady WM. Insights into the role of DNA methylation in disease through the use of mouse models. Dis Model Mech. 2010;3(5–6):290–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson B. DNA methylation and autoimmune disease. Clin Immunol (Orlando Fla). 2003;109(1):72–9.

Article  CAS  Google Scholar 

Vukic M, Daxinger L. DNA methylation in disease: Immunodeficiency, centromeric instability, facial anomalies syndrome. Essays Biochem. 2019;63(6):773–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vivekanandan P, Daniel HD-J, Kannangai R, Martinez-Murillo F, Torbenson M. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol. 2010;84(9):4321–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cicchini L, Blumhagen RZ, Westrich JA, Myers ME, Warren CJ, Siska C, et al. High-risk human papillomavirus E7 alters host DNA methylome and represses HLA-E expression in human keratinocytes. Sci Rep. 2017;7(1):3633.

Article  PubMed  PubMed Central  Google Scholar 

Matsusaka K, Funata S, Fukayama M, Kaneda A. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol. 2014;20(14):3916–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shalginskikh N, Poleshko A, Skalka AM, Katz RA. Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx. J Virol. 2013;87(4):2137–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esteban-Cantos A, Rodríguez-Centeno J, Silla JC, Barruz P, Sánchez-Cabo F, Saiz-Medrano G, et al. Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns. EBioMedicine. 2023;88:104434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arumugam T, Ramphal U, Adimulam T, Chinniah R, Ramsuran V. Deciphering DNA methylation in HIV infection. Front Immunol. 2021;12:795121.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schermelleh L, Haemmer A, Spada F, Rösing N, Meilinger D, Rothbauer U, et al. Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation. Nucleic Acids Res. 2007;35(13):4301–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247–57.

Article  CAS  PubMed  Google Scholar 

Youngblood B, Reich NO. The early expressed HIV-1 genes regulate DNMT1 expression. Epigenetics. 2008;3(3):149–56.

Article  PubMed  Google Scholar 

Luzzi A, Morettini F, Gazaneo S, Mundo L, Onnis A, Mannucci S, et al. HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Infect Agent Cancer. 2014;9:41.

Article  PubMed  PubMed Central  Google Scholar 

Doke M, Jeganathan V, McLaughlin JP, Samikkannu T. HIV-1 Tat and cocaine impact mitochondrial epigenetics: effects on DNA methylation. Epigenetics. 2021;16(9):980–99.

Article  PubMed  Google Scholar 

Stuss DP, Cheema M, Ng MK, Martinez de Paz A, Williamson B, Missiaen K, et al. Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain. Nucleic Acids Res. 2013;41(9):4888–900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gos M. Epigenetic mechanisms of gene expression regulation in neurological diseases. Acta Neurobiol Exp. 2013;73(1):19–37.

Article  Google Scholar 

Rahimian P, He JJ. HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. J Neuroinflammation. 2016;13(1):247.

Article  PubMed  PubMed Central  Google Scholar 

Re F, Braaten D, Franke EK, Luban J. Human immunodeficiency virus type 1 vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol. 1995;69(11):6859–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stewart SA, Poon B, Jowett JB, Chen IS. Human immunodeficiency virus type 1 vpr induces apoptosis following cell cycle arrest. J Virol. 1997;71(7):5579–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forget J, Yao XJ, Mercier J, Cohen EA. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. J Mol Biol. 1998;284(4):915–23.

Article  CAS  PubMed  Google Scholar 

Ayyavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, Williams WV, et al. HIV-1 vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med. 1997;3(10):1117–23.

Article  CAS  PubMed  Google Scholar 

Dehart JL, Planelles V. Human immunodeficiency virus type 1 vpr links proteasomal degradation and checkpoint activation. J Virol. 2008;82(3):1066–72.

Article  CAS  PubMed  Google Scholar 

Zhao L, Wang S, Xu M, He Y, Zhang X, Xiong Y, et al. Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages. Nat Commun. 2021;12(1):3691.

Article  PubMed  PubMed Central  Google Scholar 

Le Rouzic E, Belaïdouni N, Estrabaud E, Morel M, Rain J-C, Transy C, et al. HIV1 vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle. 2007;6(2):182–8.

Article  PubMed  Google Scholar 

Lv L, Wang Q, Xu Y, Tsao L-C, Nakagawa T, Guo H et al. Vpr targets TET2 for degradation by CRL4VprBP E3 ligase to sustain IL-6 expression and enhance HIV-1 replication. Mol Cell. 2018;70(5).

Bauby H, Ward CC, Hugh-White R, Swanson CM, Schulz R, Goujon C, et al. HIV-1 Vpr induces widespread transcriptomic changes in CD4 + T cells early Postinfection. mBio. 2021;12(3):e0136921.

Article  PubMed  Google Scholar 

Greenwood EJD, Williamson JC, Sienkiewicz A, Naamati A, Matheson NJ, Lehner PJ. Promiscuous targeting of Cellular proteins by Vpr drives systems-Level Proteomic Remodeling in HIV-1 infection. Cell Rep. 2019;27(5).

Wang Q, Su L. Vpr enhances HIV-1 Env Processing and Virion Infectivity in macrophages by modulating TET2-Dependent IFITM3 expression. mBio. 2019;10(4).

Xi Y, Li W. BSMAP: whole genome bisulfite sequence MAPping program. BMC Bioinformatics. 2009;10:232.

Article  PubMed  PubMed Central  Google Scholar 

Du X, Fan G, Jiao Y, Zhang H, Guo X, Huang R et al. The pearl oyster Pinctada Fucata martensii genome and multi-omic analyses provide insights into biomineralization. Gigascience. 2017;6(8).

Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2(Suppl 1):4–11.

Article  Google Scholar